Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 651 - 660 of 764 studies

Cancer and neoplasms

A Phase 1/2, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-3654 in Patients with Intermediate or High-risk Primary or Secondary Myelofibrosis

Early Risk Stratification by Lymph Liquid Biopsy in Malignant Melanoma and Breast Cancer

Assessing the clinical benefits of whole genome sequencing for children with neoplasms

Investigating the use of structured light plethysmography to diagnose breathing pattern disorder in patients with unexplained breathlessness

Neurological

A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP 9001 in Non-Ambulatory and Ambulatory Subjects With Duchenne Muscular Dystrophy (ENVISION)

A clinical utility study investigating the integration of machine learning algorithms into the colorectal cancer care pathway, from histopathology to the clinical multidisciplinary team. (PACES)

Development of an intra-operative mass-spectrometry tool for real-time tissue analysis during brain tumour biopsy and resection surgery

Oxford Translational Myeloma Centre Biobank

Biomarkers for individualised treatment response in amyotrophic lateral sclerosis (ITERALS)

Cancer and neoplasms

New title: A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 as Monotherapy, in Combination With Dexamethasone, Dexamethasone/Carfilzomib, Dexamethasone/Daratumumab, and Dexamethasone/Pomalidomide in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14) (Pilot 105)